Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.7 |
mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |